by Randy E. Miller | Jun 27, 2024 | FDA, FOIA, SEC
FOIAengine Reveals Trends Behind the Big Numbers at FDA, SEC This week we analyze the sources of Freedom of Information Act requests made during May to the Food and Drug Administration and the Securities and Exchange Commission. This analysis provides a macro view...
by John A. Jenkins | Jun 6, 2024 | FDA, FOIA, Law Firms, Litigation, Medical Devices
FOIAengine: Hundreds of FOIA Requests Signaled Challenge to FDA Two companies that go by the names of Triton Distribution and Vapetasia are small players in America’s fast-growing $28 billion e-cigarette market. Despite their size, they’ve become the unlikely...
by Randy E. Miller | May 30, 2024 | FDA, FOIA, Hedge Funds, News Media, Pharmaceuticals, Stock Market
FOIAengine: Requests Show FDA Still Under Pressure This week, we’re taking a closer look at the numerous Freedom of Information Act requests recently filed with the Food and Drug Administration concerning the problematic India pharmaceutical industry. As we noted in...
by John A. Jenkins | May 16, 2024 | FDA, FOIA, Litigation, Non-Profits, Politics, SEC
FOIAengine: What Does the American Accountability Foundation Want to Know – and Why? This week we’re taking a look at the more than 100 Freedom of Information Act requests recently filed by the non-profit American Accountability Foundation. This group, a pugnacious...
by Randy E. Miller | Apr 24, 2024 | FDA, FOIA, News Media, SEC
FOIAengine: Insights From the Latest FDA and SEC Requests News media outlets are among the most prolific submitters of FOIA requests to federal agencies. These requests signal – in real time – the stories that journalists are researching and writing. To illustrate...
by John A. Jenkins | Apr 11, 2024 | FDA, FOIA, Medical Devices
FOIAengine: As Deaths Mounted, J&J “Promised to Correct” – and Sought FDA Records Johnson & Johnson (NYSE: JNJ) proudly calls itself “the world’s largest and most diversified healthcare products company.” The company had $85 billion in sales last year, and...
